Global Neurothrombectomy Devices

Neurothrombectomy Devices Comprehensive Study by Type (Clot Retrievers, Aspiration/ Suction Devices, Vascular Snares, Ultrasonography technologies, Lasers), Application (Hospitals, Clinics, Others), Disease Type (Acute Ischemic Stroke, Blood Clotting Disorders, Others) Players and Region - Global Market Outlook to 2026

Neurothrombectomy Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Neurothrombectomy Devices?
Neurothrombectomy devices are used to treat acute ischemic stroke. Acute ischemic stroke is characterized by the sudden loss of blood circulation to an area of the brain generally in a vascular territory resulting in a corresponding loss of neurologic function. Neurothrembectomy device is a device intended to retrieve or destroy blood clots in the cerebral neurovasculature by mechanical, laser, ultrasound technologies, or a combination of technologies.

The market study is broken down by Type (Clot Retrievers, Aspiration/ Suction Devices, Vascular Snares, Ultrasonography technologies and Lasers), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up.

Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Neurothrombectomy Devices market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic plc (Ireland), Acandis GmbH (Germany), Stryker Corporation (United States), Phenox GmbH (Germany), Penumbra Inc. (United States) and Vesalio (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Neurothrombectomy Devices market by Type, Application and Region.

On the basis of geography, the market of Neurothrombectomy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Acute Ischemic Stroke will boost the Neurothrombectomy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • High Demand for Technically advanced Components

Market Drivers
  • Increased Prevalence of Acute Ischemic Stroke
  • Increased number of People with Obesity

Opportunities
  • Growth in the Geriatric Population
  • RIse in the Healthcare Industry

Restraints
  • Risk Associated with the Devices

Challenges
  • Less Awareness in Developing Regions


Key Target Audience
Neurothrombectomy Devices Providers, Distributors, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Clot Retrievers
  • Aspiration/ Suction Devices
  • Vascular Snares
  • Ultrasonography technologies
  • Lasers
By Application
  • Hospitals
  • Clinics
  • Others
By Disease Type
  • Acute Ischemic Stroke
  • Blood Clotting Disorders
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Acute Ischemic Stroke
      • 3.2.2. Increased number of People with Obesity
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness in Developing Regions
    • 3.4. Market Trends
      • 3.4.1. High Demand for Technically advanced Components
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurothrombectomy Devices, by Type, Application, Disease Type and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Neurothrombectomy Devices (Value)
      • 5.2.1. Global Neurothrombectomy Devices by: Type (Value)
        • 5.2.1.1. Clot Retrievers
        • 5.2.1.2. Aspiration/ Suction Devices
        • 5.2.1.3. Vascular Snares
        • 5.2.1.4. Ultrasonography technologies
        • 5.2.1.5. Lasers
      • 5.2.2. Global Neurothrombectomy Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Neurothrombectomy Devices by: Disease Type (Value)
        • 5.2.3.1. Acute Ischemic Stroke
        • 5.2.3.2. Blood Clotting Disorders
        • 5.2.3.3. Others
      • 5.2.4. Global Neurothrombectomy Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Neurothrombectomy Devices (Volume)
      • 5.3.1. Global Neurothrombectomy Devices by: Type (Volume)
        • 5.3.1.1. Clot Retrievers
        • 5.3.1.2. Aspiration/ Suction Devices
        • 5.3.1.3. Vascular Snares
        • 5.3.1.4. Ultrasonography technologies
        • 5.3.1.5. Lasers
      • 5.3.2. Global Neurothrombectomy Devices by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Neurothrombectomy Devices by: Disease Type (Volume)
        • 5.3.3.1. Acute Ischemic Stroke
        • 5.3.3.2. Blood Clotting Disorders
        • 5.3.3.3. Others
      • 5.3.4. Global Neurothrombectomy Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Neurothrombectomy Devices (Price)
      • 5.4.1. Global Neurothrombectomy Devices by: Type (Price)
  • 6. Neurothrombectomy Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Acandis GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Stryker Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Phenox GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Penumbra Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vesalio (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Neurothrombectomy Devices Sale, by Type, Application, Disease Type and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Neurothrombectomy Devices (Value)
      • 7.2.1. Global Neurothrombectomy Devices by: Type (Value)
        • 7.2.1.1. Clot Retrievers
        • 7.2.1.2. Aspiration/ Suction Devices
        • 7.2.1.3. Vascular Snares
        • 7.2.1.4. Ultrasonography technologies
        • 7.2.1.5. Lasers
      • 7.2.2. Global Neurothrombectomy Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Neurothrombectomy Devices by: Disease Type (Value)
        • 7.2.3.1. Acute Ischemic Stroke
        • 7.2.3.2. Blood Clotting Disorders
        • 7.2.3.3. Others
      • 7.2.4. Global Neurothrombectomy Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Neurothrombectomy Devices (Volume)
      • 7.3.1. Global Neurothrombectomy Devices by: Type (Volume)
        • 7.3.1.1. Clot Retrievers
        • 7.3.1.2. Aspiration/ Suction Devices
        • 7.3.1.3. Vascular Snares
        • 7.3.1.4. Ultrasonography technologies
        • 7.3.1.5. Lasers
      • 7.3.2. Global Neurothrombectomy Devices by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Neurothrombectomy Devices by: Disease Type (Volume)
        • 7.3.3.1. Acute Ischemic Stroke
        • 7.3.3.2. Blood Clotting Disorders
        • 7.3.3.3. Others
      • 7.3.4. Global Neurothrombectomy Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Neurothrombectomy Devices (Price)
      • 7.4.1. Global Neurothrombectomy Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurothrombectomy Devices: by Type(USD Million)
  • Table 2. Neurothrombectomy Devices Clot Retrievers , by Region USD Million (2015-2020)
  • Table 3. Neurothrombectomy Devices Aspiration/ Suction Devices , by Region USD Million (2015-2020)
  • Table 4. Neurothrombectomy Devices Vascular Snares , by Region USD Million (2015-2020)
  • Table 5. Neurothrombectomy Devices Ultrasonography technologies , by Region USD Million (2015-2020)
  • Table 6. Neurothrombectomy Devices Lasers , by Region USD Million (2015-2020)
  • Table 7. Neurothrombectomy Devices: by Application(USD Million)
  • Table 8. Neurothrombectomy Devices Hospitals , by Region USD Million (2015-2020)
  • Table 9. Neurothrombectomy Devices Clinics , by Region USD Million (2015-2020)
  • Table 10. Neurothrombectomy Devices Others , by Region USD Million (2015-2020)
  • Table 11. Neurothrombectomy Devices: by Disease Type(USD Million)
  • Table 12. Neurothrombectomy Devices Acute Ischemic Stroke , by Region USD Million (2015-2020)
  • Table 13. Neurothrombectomy Devices Blood Clotting Disorders , by Region USD Million (2015-2020)
  • Table 14. Neurothrombectomy Devices Others , by Region USD Million (2015-2020)
  • Table 15. South America Neurothrombectomy Devices, by Country USD Million (2015-2020)
  • Table 16. South America Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 17. South America Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 18. South America Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 19. Brazil Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 20. Brazil Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 21. Brazil Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 22. Argentina Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 23. Argentina Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 24. Argentina Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 25. Rest of South America Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 28. Asia Pacific Neurothrombectomy Devices, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 31. Asia Pacific Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 32. China Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 33. China Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 34. China Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 35. Japan Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 36. Japan Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 37. Japan Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 38. India Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 39. India Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 40. India Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 41. South Korea Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 42. South Korea Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 43. South Korea Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 44. Taiwan Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 45. Taiwan Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 46. Taiwan Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 47. Australia Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 48. Australia Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 49. Australia Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 53. Europe Neurothrombectomy Devices, by Country USD Million (2015-2020)
  • Table 54. Europe Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 55. Europe Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 56. Europe Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 57. Germany Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 58. Germany Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 59. Germany Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 60. France Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 61. France Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 62. France Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 63. Italy Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 64. Italy Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 65. Italy Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 66. United Kingdom Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 68. United Kingdom Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 69. Netherlands Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 70. Netherlands Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 71. Netherlands Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 72. Rest of Europe Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 74. Rest of Europe Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 75. MEA Neurothrombectomy Devices, by Country USD Million (2015-2020)
  • Table 76. MEA Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 77. MEA Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 78. MEA Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 79. Middle East Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 80. Middle East Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 81. Middle East Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 82. Africa Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 83. Africa Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 84. Africa Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 85. North America Neurothrombectomy Devices, by Country USD Million (2015-2020)
  • Table 86. North America Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 87. North America Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 88. North America Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 89. United States Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 90. United States Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 91. United States Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 92. Canada Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 93. Canada Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 94. Canada Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 95. Mexico Neurothrombectomy Devices, by Type USD Million (2015-2020)
  • Table 96. Mexico Neurothrombectomy Devices, by Application USD Million (2015-2020)
  • Table 97. Mexico Neurothrombectomy Devices, by Disease Type USD Million (2015-2020)
  • Table 98. Neurothrombectomy Devices Sales: by Type(K Units)
  • Table 99. Neurothrombectomy Devices Sales Clot Retrievers , by Region K Units (2015-2020)
  • Table 100. Neurothrombectomy Devices Sales Aspiration/ Suction Devices , by Region K Units (2015-2020)
  • Table 101. Neurothrombectomy Devices Sales Vascular Snares , by Region K Units (2015-2020)
  • Table 102. Neurothrombectomy Devices Sales Ultrasonography technologies , by Region K Units (2015-2020)
  • Table 103. Neurothrombectomy Devices Sales Lasers , by Region K Units (2015-2020)
  • Table 104. Neurothrombectomy Devices Sales: by Application(K Units)
  • Table 105. Neurothrombectomy Devices Sales Hospitals , by Region K Units (2015-2020)
  • Table 106. Neurothrombectomy Devices Sales Clinics , by Region K Units (2015-2020)
  • Table 107. Neurothrombectomy Devices Sales Others , by Region K Units (2015-2020)
  • Table 108. Neurothrombectomy Devices Sales: by Disease Type(K Units)
  • Table 109. Neurothrombectomy Devices Sales Acute Ischemic Stroke , by Region K Units (2015-2020)
  • Table 110. Neurothrombectomy Devices Sales Blood Clotting Disorders , by Region K Units (2015-2020)
  • Table 111. Neurothrombectomy Devices Sales Others , by Region K Units (2015-2020)
  • Table 112. South America Neurothrombectomy Devices Sales, by Country K Units (2015-2020)
  • Table 113. South America Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 114. South America Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 115. South America Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 116. Brazil Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 117. Brazil Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 118. Brazil Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 119. Argentina Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 120. Argentina Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 121. Argentina Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 122. Rest of South America Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 123. Rest of South America Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 124. Rest of South America Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 125. Asia Pacific Neurothrombectomy Devices Sales, by Country K Units (2015-2020)
  • Table 126. Asia Pacific Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 127. Asia Pacific Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 128. Asia Pacific Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 129. China Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 130. China Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 131. China Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 132. Japan Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 133. Japan Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 134. Japan Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 135. India Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 136. India Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 137. India Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 138. South Korea Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 139. South Korea Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 140. South Korea Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 141. Taiwan Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 142. Taiwan Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 143. Taiwan Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 144. Australia Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 145. Australia Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 146. Australia Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 148. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 149. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 150. Europe Neurothrombectomy Devices Sales, by Country K Units (2015-2020)
  • Table 151. Europe Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 152. Europe Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 153. Europe Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 154. Germany Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 155. Germany Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 156. Germany Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 157. France Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 158. France Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 159. France Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 160. Italy Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 161. Italy Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 162. Italy Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 163. United Kingdom Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 164. United Kingdom Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 165. United Kingdom Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 166. Netherlands Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 167. Netherlands Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 168. Netherlands Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 169. Rest of Europe Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 170. Rest of Europe Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 171. Rest of Europe Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 172. MEA Neurothrombectomy Devices Sales, by Country K Units (2015-2020)
  • Table 173. MEA Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 174. MEA Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 175. MEA Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 176. Middle East Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 177. Middle East Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 178. Middle East Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 179. Africa Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 180. Africa Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 181. Africa Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 182. North America Neurothrombectomy Devices Sales, by Country K Units (2015-2020)
  • Table 183. North America Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 184. North America Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 185. North America Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 186. United States Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 187. United States Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 188. United States Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 189. Canada Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 190. Canada Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 191. Canada Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 192. Mexico Neurothrombectomy Devices Sales, by Type K Units (2015-2020)
  • Table 193. Mexico Neurothrombectomy Devices Sales, by Application K Units (2015-2020)
  • Table 194. Mexico Neurothrombectomy Devices Sales, by Disease Type K Units (2015-2020)
  • Table 195. Neurothrombectomy Devices: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Neurothrombectomy Devices: by Type(USD Million)
  • Table 203. Neurothrombectomy Devices Clot Retrievers , by Region USD Million (2021-2026)
  • Table 204. Neurothrombectomy Devices Aspiration/ Suction Devices , by Region USD Million (2021-2026)
  • Table 205. Neurothrombectomy Devices Vascular Snares , by Region USD Million (2021-2026)
  • Table 206. Neurothrombectomy Devices Ultrasonography technologies , by Region USD Million (2021-2026)
  • Table 207. Neurothrombectomy Devices Lasers , by Region USD Million (2021-2026)
  • Table 208. Neurothrombectomy Devices: by Application(USD Million)
  • Table 209. Neurothrombectomy Devices Hospitals , by Region USD Million (2021-2026)
  • Table 210. Neurothrombectomy Devices Clinics , by Region USD Million (2021-2026)
  • Table 211. Neurothrombectomy Devices Others , by Region USD Million (2021-2026)
  • Table 212. Neurothrombectomy Devices: by Disease Type(USD Million)
  • Table 213. Neurothrombectomy Devices Acute Ischemic Stroke , by Region USD Million (2021-2026)
  • Table 214. Neurothrombectomy Devices Blood Clotting Disorders , by Region USD Million (2021-2026)
  • Table 215. Neurothrombectomy Devices Others , by Region USD Million (2021-2026)
  • Table 216. South America Neurothrombectomy Devices, by Country USD Million (2021-2026)
  • Table 217. South America Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 218. South America Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 219. South America Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 220. Brazil Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 221. Brazil Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 222. Brazil Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 223. Argentina Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 224. Argentina Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 225. Argentina Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 226. Rest of South America Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 227. Rest of South America Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 228. Rest of South America Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 229. Asia Pacific Neurothrombectomy Devices, by Country USD Million (2021-2026)
  • Table 230. Asia Pacific Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 231. Asia Pacific Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 232. Asia Pacific Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 233. China Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 234. China Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 235. China Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 236. Japan Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 237. Japan Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 238. Japan Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 239. India Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 240. India Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 241. India Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 242. South Korea Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 243. South Korea Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 244. South Korea Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 245. Taiwan Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 246. Taiwan Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 247. Taiwan Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 248. Australia Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 249. Australia Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 250. Australia Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 252. Rest of Asia-Pacific Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 253. Rest of Asia-Pacific Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 254. Europe Neurothrombectomy Devices, by Country USD Million (2021-2026)
  • Table 255. Europe Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 256. Europe Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 257. Europe Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 258. Germany Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 259. Germany Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 260. Germany Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 261. France Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 262. France Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 263. France Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 264. Italy Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 265. Italy Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 266. Italy Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 267. United Kingdom Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 268. United Kingdom Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 269. United Kingdom Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 270. Netherlands Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 271. Netherlands Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 272. Netherlands Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 273. Rest of Europe Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 274. Rest of Europe Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 275. Rest of Europe Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 276. MEA Neurothrombectomy Devices, by Country USD Million (2021-2026)
  • Table 277. MEA Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 278. MEA Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 279. MEA Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 280. Middle East Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 281. Middle East Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 282. Middle East Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 283. Africa Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 284. Africa Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 285. Africa Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 286. North America Neurothrombectomy Devices, by Country USD Million (2021-2026)
  • Table 287. North America Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 288. North America Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 289. North America Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 290. United States Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 291. United States Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 292. United States Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 293. Canada Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 294. Canada Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 295. Canada Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 296. Mexico Neurothrombectomy Devices, by Type USD Million (2021-2026)
  • Table 297. Mexico Neurothrombectomy Devices, by Application USD Million (2021-2026)
  • Table 298. Mexico Neurothrombectomy Devices, by Disease Type USD Million (2021-2026)
  • Table 299. Neurothrombectomy Devices Sales: by Type(K Units)
  • Table 300. Neurothrombectomy Devices Sales Clot Retrievers , by Region K Units (2021-2026)
  • Table 301. Neurothrombectomy Devices Sales Aspiration/ Suction Devices , by Region K Units (2021-2026)
  • Table 302. Neurothrombectomy Devices Sales Vascular Snares , by Region K Units (2021-2026)
  • Table 303. Neurothrombectomy Devices Sales Ultrasonography technologies , by Region K Units (2021-2026)
  • Table 304. Neurothrombectomy Devices Sales Lasers , by Region K Units (2021-2026)
  • Table 305. Neurothrombectomy Devices Sales: by Application(K Units)
  • Table 306. Neurothrombectomy Devices Sales Hospitals , by Region K Units (2021-2026)
  • Table 307. Neurothrombectomy Devices Sales Clinics , by Region K Units (2021-2026)
  • Table 308. Neurothrombectomy Devices Sales Others , by Region K Units (2021-2026)
  • Table 309. Neurothrombectomy Devices Sales: by Disease Type(K Units)
  • Table 310. Neurothrombectomy Devices Sales Acute Ischemic Stroke , by Region K Units (2021-2026)
  • Table 311. Neurothrombectomy Devices Sales Blood Clotting Disorders , by Region K Units (2021-2026)
  • Table 312. Neurothrombectomy Devices Sales Others , by Region K Units (2021-2026)
  • Table 313. South America Neurothrombectomy Devices Sales, by Country K Units (2021-2026)
  • Table 314. South America Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 315. South America Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 316. South America Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 317. Brazil Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 318. Brazil Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 319. Brazil Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 320. Argentina Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 321. Argentina Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 322. Argentina Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 323. Rest of South America Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 324. Rest of South America Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 325. Rest of South America Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 326. Asia Pacific Neurothrombectomy Devices Sales, by Country K Units (2021-2026)
  • Table 327. Asia Pacific Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 328. Asia Pacific Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 329. Asia Pacific Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 330. China Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 331. China Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 332. China Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 333. Japan Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 334. Japan Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 335. Japan Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 336. India Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 337. India Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 338. India Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 339. South Korea Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 340. South Korea Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 341. South Korea Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 342. Taiwan Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 343. Taiwan Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 344. Taiwan Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 345. Australia Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 346. Australia Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 347. Australia Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 348. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 349. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 350. Rest of Asia-Pacific Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 351. Europe Neurothrombectomy Devices Sales, by Country K Units (2021-2026)
  • Table 352. Europe Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 353. Europe Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 354. Europe Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 355. Germany Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 356. Germany Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 357. Germany Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 358. France Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 359. France Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 360. France Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 361. Italy Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 362. Italy Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 363. Italy Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 364. United Kingdom Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 365. United Kingdom Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 366. United Kingdom Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 367. Netherlands Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 368. Netherlands Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 369. Netherlands Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 370. Rest of Europe Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 371. Rest of Europe Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 372. Rest of Europe Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 373. MEA Neurothrombectomy Devices Sales, by Country K Units (2021-2026)
  • Table 374. MEA Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 375. MEA Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 376. MEA Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 377. Middle East Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 378. Middle East Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 379. Middle East Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 380. Africa Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 381. Africa Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 382. Africa Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 383. North America Neurothrombectomy Devices Sales, by Country K Units (2021-2026)
  • Table 384. North America Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 385. North America Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 386. North America Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 387. United States Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 388. United States Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 389. United States Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 390. Canada Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 391. Canada Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 392. Canada Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 393. Mexico Neurothrombectomy Devices Sales, by Type K Units (2021-2026)
  • Table 394. Mexico Neurothrombectomy Devices Sales, by Application K Units (2021-2026)
  • Table 395. Mexico Neurothrombectomy Devices Sales, by Disease Type K Units (2021-2026)
  • Table 396. Neurothrombectomy Devices: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurothrombectomy Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Neurothrombectomy Devices: by Application USD Million (2015-2020)
  • Figure 6. Global Neurothrombectomy Devices: by Disease Type USD Million (2015-2020)
  • Figure 7. South America Neurothrombectomy Devices Share (%), by Country
  • Figure 8. Asia Pacific Neurothrombectomy Devices Share (%), by Country
  • Figure 9. Europe Neurothrombectomy Devices Share (%), by Country
  • Figure 10. MEA Neurothrombectomy Devices Share (%), by Country
  • Figure 11. North America Neurothrombectomy Devices Share (%), by Country
  • Figure 12. Global Neurothrombectomy Devices: by Type K Units (2015-2020)
  • Figure 13. Global Neurothrombectomy Devices: by Application K Units (2015-2020)
  • Figure 14. Global Neurothrombectomy Devices: by Disease Type K Units (2015-2020)
  • Figure 15. South America Neurothrombectomy Devices Share (%), by Country
  • Figure 16. Asia Pacific Neurothrombectomy Devices Share (%), by Country
  • Figure 17. Europe Neurothrombectomy Devices Share (%), by Country
  • Figure 18. MEA Neurothrombectomy Devices Share (%), by Country
  • Figure 19. North America Neurothrombectomy Devices Share (%), by Country
  • Figure 20. Global Neurothrombectomy Devices: by Type USD/Units (2015-2020)
  • Figure 21. Global Neurothrombectomy Devices share by Players 2020 (%)
  • Figure 22. Global Neurothrombectomy Devices share by Players (Top 3) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 26. Acandis GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Acandis GmbH (Germany) Revenue: by Geography 2020
  • Figure 28. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 30. Phenox GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Phenox GmbH (Germany) Revenue: by Geography 2020
  • Figure 32. Penumbra Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Penumbra Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Vesalio (United States) Revenue, Net Income and Gross profit
  • Figure 35. Vesalio (United States) Revenue: by Geography 2020
  • Figure 36. Global Neurothrombectomy Devices: by Type USD Million (2021-2026)
  • Figure 37. Global Neurothrombectomy Devices: by Application USD Million (2021-2026)
  • Figure 38. Global Neurothrombectomy Devices: by Disease Type USD Million (2021-2026)
  • Figure 39. South America Neurothrombectomy Devices Share (%), by Country
  • Figure 40. Asia Pacific Neurothrombectomy Devices Share (%), by Country
  • Figure 41. Europe Neurothrombectomy Devices Share (%), by Country
  • Figure 42. MEA Neurothrombectomy Devices Share (%), by Country
  • Figure 43. North America Neurothrombectomy Devices Share (%), by Country
  • Figure 44. Global Neurothrombectomy Devices: by Type K Units (2021-2026)
  • Figure 45. Global Neurothrombectomy Devices: by Application K Units (2021-2026)
  • Figure 46. Global Neurothrombectomy Devices: by Disease Type K Units (2021-2026)
  • Figure 47. South America Neurothrombectomy Devices Share (%), by Country
  • Figure 48. Asia Pacific Neurothrombectomy Devices Share (%), by Country
  • Figure 49. Europe Neurothrombectomy Devices Share (%), by Country
  • Figure 50. MEA Neurothrombectomy Devices Share (%), by Country
  • Figure 51. North America Neurothrombectomy Devices Share (%), by Country
  • Figure 52. Global Neurothrombectomy Devices: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Medtronic plc (Ireland)
  • Acandis GmbH (Germany)
  • Stryker Corporation (United States)
  • Phenox GmbH (Germany)
  • Penumbra Inc. (United States)
  • Vesalio (United States)
Select User Access Type

Key Highlights of Report


Jan 2022 245 Pages 77 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neurothrombectomy Devices Quantitative research analysis
Global Neurothrombectomy Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic plc (Ireland), Acandis GmbH (Germany), Stryker Corporation (United States), Phenox GmbH (Germany), Penumbra Inc. (United States) and Vesalio (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Neurothrombectomy Devices Market to reach USD Million by 2026.

Know More About Global Neurothrombectomy Devices Report?

Have a Query? Click Here

Other Related Reports

Biomaterials Comprehensive Study by Type (Metallic Biomaterials (Stainless Steel, Titanium & Titanium Alloys, Cobalt-Chrome Alloys, Gold, Silver, Magnesium), Polymeric Biomaterials (Polymethylmethacr...
$ 3750
Insulin Syringes Comprehensive Study by Type (3/10 cc syringe, 1/2 cc syringe, 1 cc syringe, Others), Application (Hospital, Home Care, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Ductless Fume Hoods Comprehensive Study by Type (Standard Model, With Secondary Carbon Filter, With Secondary HEPA Filter), Application (Undergraduate Teaching Labs, Industrial and Biomedical Researc...
$ 3750
Medical Tuning Fork Comprehensive Study by Type (Hartmann, Rydel-Seiffer, Others), Application (Hospitals, Clinics, Ambulatory surgical centers, Others), Material (Steel Material, Aluminum Alloy Mat...
$ 3450
Silicone Hydrogel Contact Lenses Comprehensive Study by Type (Spherical Form, Toric Form, Multifocal Form), Application (Hospital Pharmacies, Optical Shop, Online Stores, Others), Design Type (Spheri...
$ 3450
Ultrasound Imaging Comprehensive Study by Type (Grey Scale Imaging {A-Mode, B-Mode, M-Mode}, Doppler Imaging {Continuous wave Doppler, Power Doppler, Color Doppler, Duplex Doppler, Pulsed wave Dopple...
$ 3800